MOTC

N/A

Report date: 2023/04/18 17:38:05

Base Information

Drug NameMOTC
Drug Alias NameMetabolic Optimized T-CellsMetabolically Optimized T-Cells
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrgenesis Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrgenesis Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A